Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4728 USD | -2.52% | -1.52% | -32.55% |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Mar. 14 | Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors | CI |
Financials (USD)
Sales 2022 | 1.68M | Sales 2023 | 1.93M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2022 | -105M | Net income 2023 | -62M | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M | Net Debt 2023 | 43.43M | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.96% |
1 day | -2.52% | ||
1 week | -1.52% | ||
Current month | -8.90% | ||
1 month | -8.90% | ||
3 months | -19.32% | ||
6 months | -37.79% | ||
Current year | -32.55% |
Managers | Title | Age | Since |
---|---|---|---|
Linda F. Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton L. Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix L. Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton L. Boynton
FOU | Founder | 79 | 96-03-17 |
Linda F. Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.4728 | -2.52% | 1,326,379 |
24-04-26 | 0.485 | +1.68% | 1,493,803 |
24-04-25 | 0.477 | +3.67% | 1,098,120 |
24-04-24 | 0.4601 | -2.54% | 1,170,694 |
24-04-23 | 0.4721 | -1.67% | 1,867,962 |
Delayed Quote OTC Markets, April 29, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-32.55% | 585M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- NWBO Stock